Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal CancerJin Li, Weiguo Su|JAMA|2018Cited by 396
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and BiomarkersYakun Wang, Lin Shen, Gongyan Chen et al.|The Oncologist|2022Cited by 15